Learn about the financial strain caused by the skyrocketing demand and costs of GLP-1 drugs, and how health plans and providers are struggling to balance it.
Compared to another common class of kidney medications, called DPP4is, GLP1-RA medications did better in helping slow the ...
Hershey's current stock decline is due to high cocoa prices, but historical trends suggest recovery once prices normalize.
Popular GLP-1 drugs may reduce risks for other conditions such as dementia, psychosis and more But they come with potential risks Side effects include nausea, vomiting, arthritis and more TUESDAY ...
Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.
Vanessa Kanu Kanu; Executive Vice President and Chief Financial Officer; Aptargroup Inc Ladies and gentlemen, thank you for standing by. Welcome to Aptar 2024 fourth quarter and annual results ...
A new study examines how cost, side effects and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
So which groundhogs have proven to be the most accurate prognosticators of an early spring or six more weeks of winter?
For a menu of food and drinks for 10 people including fan favorites, consumers will spend $139.1, virtually the same as last year ...
Glucagon-like peptide 1 receptor agonists (GLP1RA)-medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents—have been ...
Popular GLP-1 medications approved for weight loss ... benefit analysis," he said.Though people have shared personal stories of the medications' sometimes surprising side effects, such as pregnancy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results